Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)

NCT01030536

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Indianapolis, Indiana, United States
  • Research Site Bethesda, Maryland, United States
  • Research Site Las Vegas, Nevada, United States
View Trial Details
Completed

A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

NCT01453205

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Burbank, California, United States
  • Research Site Palm Springs, California, United States
  • Research Site Sylmar, California, United States
View all 81 locations
View Trial Details
Completed

Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas

NCT02271945

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site St Louis, Missouri, United States
  • Research Site The Bronx, New York, United States
View Trial Details
Completed

Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's Lymphoma

NCT01691807

Conditions
Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Southaven, Mississippi, United States
  • Novartis Investigative Site Houston, Texas, United States
  • Novartis Investigative Site San Antonio, Texas, United States
View Trial Details
Completed

Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

NCT00877006

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Teva Investigational Site 165 Tucson, Arizona, United States
  • Teva Investigational Site 167 Little Rock, Arkansas, United States
  • Teva Investigational Site 11 Corona, California, United States
  • Teva Investigational Site 21 Fountain Valley, California, United States
View all 128 locations
View Trial Details
Completed

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00445952

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +116 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • CHU de Grenoble - Hopital de la Tronche Grenoble, France
  • German Hodgkin's Lymphoma Study Group Cologne, Germany
  • Ospedale San Martino Genoa, Italy
View Trial Details

Related conditions